안감염증 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR5.4%로 성장할 전망이며, 98억 3,000만 달러로 성장이 예측됩니다. 예측 기간의 성장은 안감염증의 유병률 증가, 눈과 관련된 질환에 걸리기 쉬운 고령화 인구 증가, 당뇨병이 눈 건강에 미치는 영향의 증대, 콘택트렌즈와 관련된 감염병의 증례 증가, 안과 의료의 중요성에 대한 의식 고조 등에 기인할 것으로 보입니다. 주요 동향으로는 진단 기술의 진보, 안감염증을 위한 AI 탑재 진단 도구, 안과 치료에 있어서 3D 프린팅 기술의 통합, 희귀 안감염증을 위한 유전자 조작 치료법 개발, 선진적인 항생 물질이나 항바이러스제의 도입 등을 들 수 있습니다.
눈 관련 질환의 발생률과 유병률 증가는 안감염증 시장의 성장을 가속할 것으로 예측됩니다. 눈 관련 질환에는 녹내장, 백내장, 황반변성증, 근시나 원시 등의 굴절 이상 등 눈에 영향을 미치는 다양한 질환이 포함됩니다. 이러한 질환의 환자수 증가는, 인구의 고령화, 라이프 스타일의 변화, 환경 요인, 조기 발견을 늦추는 진단 능력 격차 등의 요인에 영향을 받고 있습니다. 안감염증은 염증, 조직 손상, 눈의 자연스러운 방어 기능 저하를 야기함으로써 이러한 장애를 악화시키거나 조장시킬 수 있으며, 시력 저하나 만성 증상 등의 합병증을 일으킬 수 있습니다. 예를 들어 2024년 10월 스위스에 본부를 둔 보건당국인 세계보건기구(WHO)는 2023년 13만 746명이 진행한 트라코마 외과 치료를 받고 3290만 명이 항생제를 투여받아 세계 커버율이 29%에 달했다고 보고했습니다. 그 결과 눈과 관련된 질환의 유병률 증가가 안감염증 시장의 확대를 촉진할 것으로 예상됩니다.
안감염증 시장의 기업은 치료 결과를 개선하고 부작용을 최소화하기 위해 광역학 치료과 같은 혁신적인 치료에 점점 더 많은 힘을 쏟고 있습니다. 광역학적 요법은 특정 빛의 파장에 의해 활성화되는 광감수성 약제를 사용하여 감염 세포나 이상 세포를 선택적으로 표적으로 파괴하는 것입니다. 예를 들어 2024년 12월 미국 임상 단계의 생명공학 기업인 VisiRose Inc.는 미국 제약회사인 Provectus Biopharmaceuticals Inc. 및 미국 의료센터인 Bascom Palmer Eye Institute와 손잡고 로즈벵골 광역학적 항균요법(RB PDAT)을 도입했습니다. 감염성 각막염이나 그 외의 중증의 안감염증에 대한 이 신규로 비침습적인 치험적 치료는, 광범위한 안과 치료를 제공하는 것으로, 항균약 내성(AMR)의 증대라고 하는 세계의 과제에 대처하는 것을 목적으로 하고 있습니다. 안전성, 유효성, 비용 효율이 뛰어난 이 치료법은 안과 영역의 혁신적인 솔루션에 대한 긴급한 요구에 부응합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장-거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
- 세계의 안감염증 시장 보고서(2024년) PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
- 최종 이용 산업의 분석
- 세계의 안감염증 시장 보고서(2024년) 시장 : 성장률 분석
- 세계의 안감염증 시장 보고서(2024년) 시장 : 규모 실적 및 성장(2019-2024년)
- 세계의 안감염증 시장 보고서(2024년) 예측 시장 : 규모 및 성장(2024-2029년, 2034년)
- 세계의 안감염증 시장 보고서(2024년) 전체 시장 규모(TAM)
제6장 시장 세분화
- 세계의 안감염증 시장 보고서(2024년) 시장 : 적응증별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 결막염
- 각막염
- 안내염
- 안검염
- 밀립종
- 포도막염
- 벌와직염
- 안구 헤르페스
- 세계의 안감염증 시장 보고서(2024년) 시장 : 의약품 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 코르티코스테로이드
- 퀴놀론계 항생제
- 마크로라이드계 항생제
- 테트라사이클린계 항생제
- 폴리엔계 항진균제
- 세계의 안감염증 시장 보고서(2024년) 시장 : 유통 채널별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 병원 약국
- 소매 약국
- 온라인 약국
- 세계의 안감염증 시장 보고서(2024년) 시장 : 결막염 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 세균성 결막염
- 바이러스성 결막염
- 알레르기성 결막염
- 세계의 안감염증 시장 보고서(2024년) 시장 : 각막염 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 세균성 각막염
- 바이러스성 각막염
- 진균성 각막염
- 아칸사메바 각막염
- 세계의 안감염증 시장 보고서(2024년) 시장 : 안내염별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 수술 후 안내염
- 외상 후 안내염
- 내인성 안구염
- 세계의 안감염증 시장 보고서(2024년) 시장 : 안검염 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 전안검염
- 후안검염
- 세계의 안감염증 시장 보고서(2024년) 시장 : 모달 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 내밀립종
- 외맥립종
- 세계의 안감염증 시장 보고서(2024년) 시장 : 포도막염 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 정면 포도막염
- 중간 포도막염
- 후부 포도막염
- 포도막염
- 세계의 안감염증 시장 보고서(2024년) 시장 : 봉와직염 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 안와 주위 봉와직염
- 안와 봉와직염
- 세계의 안감염증 시장 보고서(2024년) 시장 : 안헤르페스 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 단순 헤르페스 각막염
- 단순 헤르페스 결막염
제7장 지역별 및 국가별 분석
- 세계의 안감염증 시장 보고서(2024년) : 지역별 시장 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 세계의 안감염증 시장 보고서(2024년) : 국가별 시장 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
- 세계의 안감염증 시장 보고서(2024년) 시장 경쟁 구도
- 세계의 안감염증 시장 보고서(2024년) 시장 기업 프로파일
- Pfizer Inc 개요, 제품 및 서비스, 전략 및 재무 분석
- F. Hoffmann-La Roche AG 개요, 제품 및 서비스, 전략 및 재무 분석
- Merck And Co Inc 개요, 제품 및 서비스, 전략 및 재무 분석
- AbbVie Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- Abbott Laboratories 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- Novartis AG
- Takeda Pharmaceutical Company Limited
- Essilor International SA
- Teva Pharmaceutical Industries Limited
- Otsuka Pharmaceutical Co Ltd
- Regeneron Pharmaceuticals Inc
- Alcon Laboratories Inc.
- Bausch Health Companies Inc.
- Sun Pharmaceutical Industries Limited
- Carl Zeiss Meditec AG
- Santen Pharmaceuticals Co Ltd
- Rohto Pharmaceutical Co Ltd
- Topcon Corporation
- Akorn Pharmaceuticals
- Alembic Pharmaceuticals Limited
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
- 세계의 안감염증 시장 보고서(2024년) 시장(2029년) : 가장 새로운 기회를 제공하는 국가
- 세계의 안감염증 시장 보고서(2024년) 시장(2029년) : 가장 새로운 기회를 제공하는 부문
- 세계의 안감염증 시장 보고서(2024년) 시장(2029년) : 성장 전략
제36장 부록
AJY
Eye infections occur when harmful microorganisms such as bacteria, viruses, or fungi invade parts of the eye, causing inflammation, discomfort, and, in some cases, vision impairment. These infections can affect the eyelid, cornea, conjunctiva, or deeper eye structures, with common symptoms including redness, pain, discharge, swelling, and sensitivity to light. Since some eye infections are contagious, prompt medical treatment is essential to prevent complications.
The primary indications of eye infections include conjunctivitis, keratitis, endophthalmitis, blepharitis, stye, uveitis, cellulitis, and ocular herpes. Conjunctivitis, or pink eye, refers to the inflammation or infection of the conjunctiva, the thin, transparent tissue lining the inner eyelids and covering the white part of the eyeball. Treatment options generally consist of corticosteroids, quinolone antibiotics, macrolide antibiotics, tetracycline antibiotics, and polyene antifungals. These medications are distributed through hospital pharmacies, retail pharmacies, and online pharmacies.
The eye infections market research report is one of a series of new reports from The Business Research Company that provides eye infections market statistics, including the eye infections industry global market size, regional shares, competitors with the eye infections market share, detailed eye infections market segments, market trends, and opportunities, and any further data you may need to thrive in the eye infections industry. This eye infections market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The eye infections market size has grown strongly in recent years. It will grow from $7.53 billion in 2024 to $7.96 billion in 2025 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to increased exposure to environmental pollutants causing eye irritations, a higher incidence of eye infections in children, rising medical tourism for eye surgeries, growing demand for combination therapies to treat complex infections, and a rise in allergic conjunctivitis cases.
The eye infections market size is expected to see strong growth in the next few years. It will grow to $9.83 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to the increasing prevalence of eye infections, the rising aging population prone to eye-related conditions, the growing impact of diabetes on eye health, the increasing cases of contact lens-related infections, and greater awareness about the importance of eye care. Major trends include advancements in diagnostic technologies, AI-powered diagnostic tools for eye infections, the integration of 3D printing technology in ophthalmic treatments, the development of genetically engineered therapies for rare eye infections, and the introduction of advanced antibiotics and antivirals.
The rising incidence and prevalence of eye-related disorders are expected to drive growth in the eye infections market. Eye-related disorders encompass a variety of conditions affecting the eyes, including diseases such as glaucoma, cataracts, macular degeneration, and refractive errors such as myopia and hyperopia. The increasing number of patients with these conditions is influenced by factors such as aging populations, lifestyle changes, environmental factors, and gaps in diagnostic capabilities that delay early detection. Eye infections can exacerbate or contribute to these disorders by causing inflammation, tissue damage, and weakening the eye's natural defenses, potentially leading to complications such as vision loss or chronic conditions. For instance, in October 2024, the World Health Organization, a Switzerland-based health authority, reported that in 2023, 130,746 individuals underwent surgical treatment for advanced trachoma, while 32.9 million people received antibiotics, achieving a global coverage of 29%. As a result, the growing prevalence of eye-related disorders is expected to fuel expansion in the eye infections market.
Companies in the eye infections market are increasingly focusing on innovative therapies such as photodynamic therapy to improve treatment outcomes and minimize side effects. Photodynamic therapy involves using a light-sensitive drug activated by specific light wavelengths to selectively target and destroy infected or abnormal cells. For example, in December 2024, VisiRose Inc., a US-based clinical-stage biotechnology company, partnered with Provectus Biopharmaceuticals Inc., a US-based pharmaceutical firm, and Bascom Palmer Eye Institute, a US-based health center, to introduce Rose Bengal Photodynamic Antimicrobial Therapy (RB PDAT). This novel, non-invasive investigational treatment for infectious keratitis and other severe eye infections aims to address the growing global challenge of antimicrobial resistance (AMR) by offering a broad-spectrum ocular treatment. Designed to be safe, effective, and cost-efficient, this therapy meets the urgent need for innovative solutions in ophthalmology.
In July 2024, Merck And Co., Inc., a US-based science and technology company specializing in the development of medicines, vaccines, and health solutions, acquired EyeBio for $3 billion. This acquisition enables Merck to expand its ophthalmology pipeline and advance the development of innovative treatments for retinal diseases. Eyebiotech Limited, a UK-based biotechnology company, focuses on developing therapies for eye diseases.
Major players in the eye infections market are Pfizer Inc, F. Hoffmann-La Roche AG, Merck And Co Inc, AbbVie Inc., Abbott Laboratories, Novartis AG, Takeda Pharmaceutical Company Limited, Essilor International S.A., Teva Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co Ltd, Regeneron Pharmaceuticals Inc, Alcon Laboratories Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Limited, Carl Zeiss Meditec AG, Santen Pharmaceuticals Co Ltd, Rohto Pharmaceutical Co Ltd, Topcon Corporation, Akorn Pharmaceuticals, Alembic Pharmaceuticals Limited, Novaliq GmbH, Eyevance Pharmaceuticals LLC, Ocular Therapeutix, I-Med Pharma Inc., and EyeGate Pharmaceuticals Inc.
North America was the largest region in the eye infections market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in eye infections report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the eye infections market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The eye infections market consists of sales of antibiotics, antifungal drugs, antiviral drugs, steroid eye drops, and surgical interventions. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Eye Infections Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on eye infections market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for eye infections ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The eye infections market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Indications: Conjunctivitis; Keratitis; Endophthalmitis; Blepharitis; Stye; Uveitis; Cellulitis; Ocular Herpes
- 2) By Drug Type: Corticosteroids; Quinolone Antibiotics; Macrolide Antibiotics; Tetracycline Antibiotics; Polyene Antifungals
- 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
- Subsegments:
- 1) By Conjunctivitis: Bacterial Conjunctivitis; Viral Conjunctivitis; Allergic Conjunctivitis
- 2) By Keratitis: Bacterial Keratitis; Viral Keratitis; Fungal Keratitis; Acanthamoeba Keratitis
- 3) By Endophthalmitis: Post-surgical Endophthalmitis; Post-traumatic Endophthalmitis; Endogenous Endophthalmitis
- 4) By Blepharitis: Anterior Blepharitis; Posterior Blepharitis
- 5) By Stye: Internal Stye; External Stye
- 6) By Uveitis: Anterior Uveitis; Intermediate Uveitis; Posterior Uveitis; Panuveitis
- 7) By Cellulitis: Periorbital Cellulitis; Orbital Cellulitis
- 8) By Ocular Herpes: Herpes Simplex Keratitis; Herpes Simplex Conjunctivitis
- Companies Mentioned: Pfizer Inc; F. Hoffmann-La Roche AG; Merck And Co Inc; AbbVie Inc.; Abbott Laboratories
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Eye Infections Global Market Report 2024 Market Characteristics
3. Eye Infections Global Market Report 2024 Market Trends And Strategies
4. Eye Infections Global Market Report 2024 Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Eye Infections Global Market Report 2024 Growth Analysis And Strategic Analysis Framework
- 5.1. Global Eye Infections Global Market Report 2024 PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Eye Infections Global Market Report 2024 Market Growth Rate Analysis
- 5.4. Global Eye Infections Global Market Report 2024 Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Eye Infections Global Market Report 2024 Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Eye Infections Global Market Report 2024 Total Addressable Market (TAM)
6. Eye Infections Global Market Report 2024 Market Segmentation
- 6.1. Global Eye Infections Global Market Report 2024 Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Conjunctivitis
- Keratitis
- Endophthalmitis
- Blepharitis
- Stye
- Uveitis
- Cellulitis
- Ocular Herpes
- 6.2. Global Eye Infections Global Market Report 2024 Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Corticosteroids
- Quinolone Antibiotics
- Macrolide Antibiotics
- Tetracycline Antibiotics
- Polyene Antifungals
- 6.3. Global Eye Infections Global Market Report 2024 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- 6.4. Global Eye Infections Global Market Report 2024 Market, Sub-Segmentation Of Conjunctivitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Bacterial Conjunctivitis
- Viral Conjunctivitis
- Allergic Conjunctivitis
- 6.5. Global Eye Infections Global Market Report 2024 Market, Sub-Segmentation Of Keratitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Bacterial Keratitis
- Viral Keratitis
- Fungal Keratitis
- Acanthamoeba Keratitis
- 6.6. Global Eye Infections Global Market Report 2024 Market, Sub-Segmentation Of Endophthalmitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Post-surgical Endophthalmitis
- Post-traumatic Endophthalmitis
- Endogenous Endophthalmitis
- 6.7. Global Eye Infections Global Market Report 2024 Market, Sub-Segmentation Of Blepharitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Anterior Blepharitis
- Posterior Blepharitis
- 6.8. Global Eye Infections Global Market Report 2024 Market, Sub-Segmentation Of Stye, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Internal Stye
- External Stye
- 6.9. Global Eye Infections Global Market Report 2024 Market, Sub-Segmentation Of Uveitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Anterior Uveitis
- Intermediate Uveitis
- Posterior Uveitis
- Panuveitis
- 6.10. Global Eye Infections Global Market Report 2024 Market, Sub-Segmentation Of Cellulitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Periorbital Cellulitis
- Orbital Cellulitis
- 6.11. Global Eye Infections Global Market Report 2024 Market, Sub-Segmentation Of Ocular Herpes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Herpes Simplex Keratitis
- Herpes Simplex Conjunctivitis
7. Eye Infections Global Market Report 2024 Market Regional And Country Analysis
- 7.1. Global Eye Infections Global Market Report 2024 Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Eye Infections Global Market Report 2024 Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Eye Infections Global Market Report 2024 Market
- 8.1. Asia-Pacific Eye Infections Global Market Report 2024 Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Eye Infections Global Market Report 2024 Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Eye Infections Global Market Report 2024 Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Eye Infections Global Market Report 2024 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Eye Infections Global Market Report 2024 Market
- 9.1. China Eye Infections Global Market Report 2024 Market Overview
- 9.2. China Eye Infections Global Market Report 2024 Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Eye Infections Global Market Report 2024 Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Eye Infections Global Market Report 2024 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Eye Infections Global Market Report 2024 Market
- 10.1. India Eye Infections Global Market Report 2024 Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Eye Infections Global Market Report 2024 Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Eye Infections Global Market Report 2024 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Eye Infections Global Market Report 2024 Market
- 11.1. Japan Eye Infections Global Market Report 2024 Market Overview
- 11.2. Japan Eye Infections Global Market Report 2024 Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Eye Infections Global Market Report 2024 Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Eye Infections Global Market Report 2024 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Eye Infections Global Market Report 2024 Market
- 12.1. Australia Eye Infections Global Market Report 2024 Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Eye Infections Global Market Report 2024 Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Eye Infections Global Market Report 2024 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Eye Infections Global Market Report 2024 Market
- 13.1. Indonesia Eye Infections Global Market Report 2024 Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Eye Infections Global Market Report 2024 Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Eye Infections Global Market Report 2024 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Eye Infections Global Market Report 2024 Market
- 14.1. South Korea Eye Infections Global Market Report 2024 Market Overview
- 14.2. South Korea Eye Infections Global Market Report 2024 Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Eye Infections Global Market Report 2024 Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Eye Infections Global Market Report 2024 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Eye Infections Global Market Report 2024 Market
- 15.1. Western Europe Eye Infections Global Market Report 2024 Market Overview
- 15.2. Western Europe Eye Infections Global Market Report 2024 Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Eye Infections Global Market Report 2024 Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Eye Infections Global Market Report 2024 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Eye Infections Global Market Report 2024 Market
- 16.1. UK Eye Infections Global Market Report 2024 Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Eye Infections Global Market Report 2024 Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Eye Infections Global Market Report 2024 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Eye Infections Global Market Report 2024 Market
- 17.1. Germany Eye Infections Global Market Report 2024 Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Eye Infections Global Market Report 2024 Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Eye Infections Global Market Report 2024 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Eye Infections Global Market Report 2024 Market
- 18.1. France Eye Infections Global Market Report 2024 Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Eye Infections Global Market Report 2024 Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Eye Infections Global Market Report 2024 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Eye Infections Global Market Report 2024 Market
- 19.1. Italy Eye Infections Global Market Report 2024 Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Eye Infections Global Market Report 2024 Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Eye Infections Global Market Report 2024 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Eye Infections Global Market Report 2024 Market
- 20.1. Spain Eye Infections Global Market Report 2024 Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Eye Infections Global Market Report 2024 Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Eye Infections Global Market Report 2024 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Eye Infections Global Market Report 2024 Market
- 21.1. Eastern Europe Eye Infections Global Market Report 2024 Market Overview
- 21.2. Eastern Europe Eye Infections Global Market Report 2024 Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Eye Infections Global Market Report 2024 Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Eye Infections Global Market Report 2024 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Eye Infections Global Market Report 2024 Market
- 22.1. Russia Eye Infections Global Market Report 2024 Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Eye Infections Global Market Report 2024 Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Eye Infections Global Market Report 2024 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Eye Infections Global Market Report 2024 Market
- 23.1. North America Eye Infections Global Market Report 2024 Market Overview
- 23.2. North America Eye Infections Global Market Report 2024 Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Eye Infections Global Market Report 2024 Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Eye Infections Global Market Report 2024 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Eye Infections Global Market Report 2024 Market
- 24.1. USA Eye Infections Global Market Report 2024 Market Overview
- 24.2. USA Eye Infections Global Market Report 2024 Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Eye Infections Global Market Report 2024 Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Eye Infections Global Market Report 2024 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Eye Infections Global Market Report 2024 Market
- 25.1. Canada Eye Infections Global Market Report 2024 Market Overview
- 25.2. Canada Eye Infections Global Market Report 2024 Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Eye Infections Global Market Report 2024 Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Eye Infections Global Market Report 2024 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Eye Infections Global Market Report 2024 Market
- 26.1. South America Eye Infections Global Market Report 2024 Market Overview
- 26.2. South America Eye Infections Global Market Report 2024 Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Eye Infections Global Market Report 2024 Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Eye Infections Global Market Report 2024 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Eye Infections Global Market Report 2024 Market
- 27.1. Brazil Eye Infections Global Market Report 2024 Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Eye Infections Global Market Report 2024 Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Eye Infections Global Market Report 2024 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Eye Infections Global Market Report 2024 Market
- 28.1. Middle East Eye Infections Global Market Report 2024 Market Overview
- 28.2. Middle East Eye Infections Global Market Report 2024 Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Eye Infections Global Market Report 2024 Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Eye Infections Global Market Report 2024 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Eye Infections Global Market Report 2024 Market
- 29.1. Africa Eye Infections Global Market Report 2024 Market Overview
- 29.2. Africa Eye Infections Global Market Report 2024 Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Eye Infections Global Market Report 2024 Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Eye Infections Global Market Report 2024 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Eye Infections Global Market Report 2024 Market Competitive Landscape And Company Profiles
- 30.1. Eye Infections Global Market Report 2024 Market Competitive Landscape
- 30.2. Eye Infections Global Market Report 2024 Market Company Profiles
- 30.2.1. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck And Co Inc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
31. Eye Infections Global Market Report 2024 Market Other Major And Innovative Companies
- 31.1. Novartis AG
- 31.2. Takeda Pharmaceutical Company Limited
- 31.3. Essilor International S.A.
- 31.4. Teva Pharmaceutical Industries Limited
- 31.5. Otsuka Pharmaceutical Co Ltd
- 31.6. Regeneron Pharmaceuticals Inc
- 31.7. Alcon Laboratories Inc.
- 31.8. Bausch Health Companies Inc.
- 31.9. Sun Pharmaceutical Industries Limited
- 31.10. Carl Zeiss Meditec AG
- 31.11. Santen Pharmaceuticals Co Ltd
- 31.12. Rohto Pharmaceutical Co Ltd
- 31.13. Topcon Corporation
- 31.14. Akorn Pharmaceuticals
- 31.15. Alembic Pharmaceuticals Limited
32. Global Eye Infections Global Market Report 2024 Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Eye Infections Global Market Report 2024 Market
34. Recent Developments In The Eye Infections Global Market Report 2024 Market
35. Eye Infections Global Market Report 2024 Market High Potential Countries, Segments and Strategies
- 35.1 Eye Infections Global Market Report 2024 Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Eye Infections Global Market Report 2024 Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Eye Infections Global Market Report 2024 Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
